Health and Healthcare
Health and Healthcare Articles
Clinical-stage, drug platform company Annovis Bio entered the market with a bang on Wednesday.
Published:
Teva Pharmaceuticals has been under fire for its role in the opioid crisis and for pricing fixing of some drugs, often at many times their market value. Is there any sign of a turn around for this...
Published:
Pfizer stock retreated after it released a disappointing fourth-quarter earnings report before the opening bell Tuesday.
Published:
The January 15 short interest data have been compared with the previous figures, and short interest in most of these selected pharmaceutical stocks decreased.
Published:
The January 15 short interest data has been compared with the previous report, and short interest in most of these selected biotech stocks decreased.
Published:
If there is one group that can produce stock gains regardless of the daily market activities, that would be biotechnology and emerging pharmaceuticals. Coming up with a new approach or new way to...
Published:
These three health care companies included are expected to report their earnings on Tuesday morning.
Published:
As with almost all pandemic scares and other national and global issues, some speculative stocks manage to see their shares rise sharply.
Published:
Canada-based marijuana grower Aphria announced Friday morning a strategic investment of C$100 million. The stock is getting beaten up based on a discount of around 6% to Thursday's closing price for...
Published:
Why Credit Suisse believes that this round of quarterly biotech earnings could prove to be a catalyst for 2020.
Published:
New research shows that several members of the coronavirus family are susceptible to inactivation via a system developed by biomedical products company Cerus.
Published:
Applied Genetic Technologies' shares were crushed early on Thursday after the firm reported interim data from its midstage trial in patients with achromatopsia.
Published:
Akcea Therapeutics and Ionis Pharmaceuticals each made handy gains on Wednesday after the firms reported midstage results for their cardiovascular disease study.
Published:
Neurotrope released a corporate update after analyzing data from its recently reported Phase 2 confirmatory clinical trial examining moderately severe to severe Alzheimer's disease patients.
Published:
Health care giant Johnson & Johnson reported fourth-quarter and full-year 2019 results Wednesday morning. The company posted narrow beats and investors have reacted coolly to guidance.
Published:
Our expert who first called NVIDIA in 2009 is predicting 2025 will see a historic AI breakthrough.
You can follow him investing $500,000 of his own money on our top AI stocks for free.